查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1572314

膽紅素血液檢測市場：按測試類型、最終用戶、應用、產品 - 2025-2030 年全球預測

Bilirubin Blood Test Market by Test Type (Delta Bilirubin Test, Direct Bilirubin Test, Indirect Bilirubin Test), End User (Ambulatory Surgical Centers, Diagnostic Laboratories, Home Care Settings), Application, Product - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年膽紅素血液檢測市值為10.9億美元，預計到2024年將達到12億美元，複合年成長率為10.73%，預計到2030年將達到22.3億美元。

膽紅素血液檢測市場包括測量血液中膽紅素濃度的診斷程序，這對於肝病、溶血性貧血和新生兒黃疸的診斷和監測至關重要。生活方式改變、飲酒和肝炎等病毒感染引起的肝損傷日益普遍，強調了對這些檢查的必要性。最終用途主要包括醫院、診斷實驗室和門診護理中心，每個地方都需要準確、及時的診斷服務來幫助病患管理。市場成長受到對先進診斷技術的需求不斷成長、人們對肝臟健康的認知不斷提高以及更容易患肝病的老年人口不斷增加的影響。此外，就地檢驗和非侵入性診斷工具的開發等技術創新提供了巨大的成長機會。投資研發更準確、更方便的測試的公司將充分利用快速成長的需求。然而，市場面臨嚴格的監管要求和與先進測試技術相關的高成本等挑戰，這可能會限制小規模的測試設施和新興國家。在創新方面，探索人工智慧主導的診斷工具以提高測試準確性和患者治療結果具有廣闊的前景。此外，對家庭環境中膽紅素測試更加無縫整合的研究可能會開拓新的細分市場。儘管有這些機會，但市場在一定程度上受到新興市場意識低落和醫療基礎設施不足的限制，凸顯了教育宣傳活動和基礎設施投資的必要性。總體而言，透過技術進步和策略聯盟來提高測試的可及性、準確性和可負擔性對於市場參與者在克服現有限制的同時開拓這一利基市場至關重要。隨著市場的發展，它將為創新提供肥沃的土壤，特別是在個人化醫療和行動醫療技術方面。

主要市場統計
基準年[2023] 10.9億美元
預測年份 [2024] 12億美元
預測年份 [2030] 22.3億美元
複合年成長率（%） 10.73%

市場動態：快速發展的膽紅素血液檢測市場的關鍵市場洞察

供需的動態交互作用正在改變膽紅素血液檢測市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 由於新生兒保健服務的擴大，對新生兒膽紅素檢測的需求增加
    • 就地檢驗的普及有助於方便、快速地獲得膽紅素結果
    • 需要頻繁監測膽紅素的溶血性疾病發生率不斷增加，有助於市場成長
    • 政府衛生政策和資金推動膽紅素檢測的進步和可及性
  • 市場限制因素
    • 缺乏接受過膽紅素檢測技術培訓的熟練醫療保健專業人員，特別是在農村地區
    • 新膽紅素檢測方法和技術的監管核准過程漫長；
  • 市場機會
    • 支持在農村推廣膽紅素血液檢測的醫療保健政策
    • 由於對新生兒黃疸的認知不斷提高，對膽紅素檢測的需求增加
    • 醫院與研究機構夥伴關係開發創新膽紅素檢測解決方案
  • 市場挑戰
    • 供應鏈中斷影響膽紅素血液檢測套組的及時且經濟高效的分發
    • 核准過程中的監管挑戰導致創新膽紅素檢測技術的引入延遲

波特的五力：駕馭膽紅素血液檢測市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解膽紅素血液檢測市場的外部影響

外部宏觀環境因素在塑造膽紅素血液檢測市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解膽紅素血液檢測市場的競爭格局

對膽紅素血液檢測市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣膽紅素血液檢測市場供應商的績效評估

FPNV定位矩陣是評估膽紅素血液檢測市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃膽紅素血液檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，膽紅素血液檢測市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 新生兒保健服務的擴展增加了新生兒膽紅素檢測的需求
      • 隨著醫療環境檢測的迅速增加，現在可以方便快速地獲得膽紅素水平的檢測結果。
      • 需要頻繁監測膽紅素的溶血性疾病發生率上升有助於市場成長
      • 促進膽紅素檢測的進步和可近性的政府衛生政策和資金
    • 抑制因素
      • 缺乏接受過膽紅素檢測技術訓練的熟練醫護人員，特別是在農村地區。
      • 新膽紅素檢測方法和技術的監管核准流程較長
    • 機會
      • 支持在農村地區廣泛使用膽紅素血液檢測的醫療保健政策
      • 對新生兒黃疸的認知提高增加了對膽紅素檢測的需求
      • 醫院與研究機構合作開發創新膽紅素檢測解決方案
    • 任務
      • 供應鏈中斷導致膽紅素血液檢測套組無法及時且經濟有效地分發
      • 核准過程中的監管挑戰延遲了創新膽紅素測試技術的引入
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章膽紅素血液檢測市場：依測試類型

  • Delta膽紅素測試
  • 直接膽紅素（DBIL）測試
  • 間接膽紅素（IBIL）測試
  • 血清總膽紅素（TSB）測試
    • 直接（結合）膽紅素測試
    • 間接（非結合）膽紅素測試

第7章膽紅素血液檢測市場：依最終用戶分類

  • 日間手術中心 (ASC)
  • 診斷實驗室
  • 家庭護理設置
  • 醫院
  • 研究所

第8章膽紅素血液檢測市場：依應用分類

  • 膽管阻塞
  • 藥物相關毒性
  • 溶血性貧血
  • 肝臟疾病
  • 新生兒黃疸

第9章膽紅素血液檢測市場：依產品

  • 裝置
  • 試劑和套件

第10章美洲膽紅素血液檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太膽紅素血液檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲膽紅素血液檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C0149

The Bilirubin Blood Test Market was valued at USD 1.09 billion in 2023, expected to reach USD 1.20 billion in 2024, and is projected to grow at a CAGR of 10.73%, to USD 2.23 billion by 2030.

The bilirubin blood test market, encompassing diagnostic procedures to measure bilirubin levels in the blood, is pivotal in diagnosing and monitoring liver diseases, hemolytic anemia, and neonatal jaundice. The necessity of these tests is underscored by the increasing prevalence of liver disorders, driven by lifestyle changes, alcohol consumption, and viral infections like hepatitis. End-use applications predominantly include hospitals, diagnostic laboratories, and outpatient care centers, each requiring precise and timely diagnostic services to aid in patient management. Market growth is influenced by the rising demand for advanced diagnostic techniques, heightened awareness about liver health, and the increasing geriatric population, prone to liver diseases. Additionally, technological innovations such as point-of-care testing and the development of non-invasive diagnostic tools present substantial growth opportunities. Companies investing in R&D for more accurate and accessible testing methods stand to capitalize on the burgeoning demand. However, the market faces challenges like stringent regulatory requirements and the high costs associated with advanced testing technologies, which may constrain smaller laboratories and emerging economies. In terms of innovation, there is promising potential in exploring artificial intelligence-driven diagnostic tools to enhance test accuracy and patient outcomes. Additionally, research into more seamless integration of bilirubin testing in home-based settings could open new market segments. Despite these opportunities, the market is somewhat constrained by the lack of awareness and inadequate healthcare infrastructure in developing regions, highlighting a need for educational campaigns and infrastructure investments. Overall, focusing on enhancing test accessibility, accuracy, and affordability through technological advancements and strategic partnerships would be pivotal for market players to exploit this niche while overcoming existing limitations. As the market evolves, it presents a fertile ground for innovation, particularly in personalized medicine and mobile health technologies.

KEY MARKET STATISTICS
Base Year [2023] USD 1.09 billion
Estimated Year [2024] USD 1.20 billion
Forecast Year [2030] USD 2.23 billion
CAGR (%) 10.73%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bilirubin Blood Test Market

The Bilirubin Blood Test Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expansion of neonatal healthcare services increasing demand for bilirubin testing in newborns
    • Surge in point-of-care testing driving convenience and faster results for bilirubin levels
    • Higher incidence of hemolytic diseases requiring frequent bilirubin monitoring contributing to market growth
    • Government health policies and funding favoring advancements and accessibility of bilirubin testing
  • Market Restraints
    • Shortage of skilled healthcare professionals trained in bilirubin testing techniques, especially in rural areas
    • Long approval process for new bilirubin test methods and technologies by regulatory bodies
  • Market Opportunities
    • Healthcare policies supporting widespread adoption of bilirubin blood tests in rural areas
    • Rising awareness about neonatal jaundice leading to increased bilirubin testing demand
    • Partnerships between hospitals and research institutions for innovative bilirubin test solutions
  • Market Challenges
    • Supply chain disruptions affecting timely and cost-efficient distribution of bilirubin blood test kits
    • Regulatory challenges in approval processes leading to delayed introduction of innovative bilirubin testing technologies

Porter's Five Forces: A Strategic Tool for Navigating the Bilirubin Blood Test Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bilirubin Blood Test Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bilirubin Blood Test Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bilirubin Blood Test Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bilirubin Blood Test Market

A detailed market share analysis in the Bilirubin Blood Test Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bilirubin Blood Test Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bilirubin Blood Test Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bilirubin Blood Test Market

A strategic analysis of the Bilirubin Blood Test Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bilirubin Blood Test Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Beckman Coulter, Bio-Rad Laboratories, DiaSorin, Fujifilm Holdings Corporation, GE Healthcare, Horiba Medical, Mindray, PerkinElmer, Philips Healthcare, Quidel Corporation, Randox Laboratories, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Tosoh Bioscience, and Trinity Biotech.

Market Segmentation & Coverage

This research report categorizes the Bilirubin Blood Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test Type, market is studied across Delta Bilirubin Test, Direct Bilirubin (DBIL) Test, Indirect Bilirubin (IBIL) Test, and Total Serum Bilirubin (TSB) Test. The Total Serum Bilirubin (TSB) Test is further studied across Direct (Conjugated) Bilirubin Test and Indirect (Unconjugated) Bilirubin Test.
  • Based on End User, market is studied across Ambulatory Surgical Centers (ASCs), Diagnostic Laboratories, Home Care Settings, Hospitals, and Research Institutes.
  • Based on Application, market is studied across Bile Duct Obstruction, Drug-Related Toxicity, Hemolytic Anemia, Liver Diseases, and Newborn Jaundice.
  • Based on Product, market is studied across Instruments and Reagents & Kits.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion of neonatal healthcare services increasing demand for bilirubin testing in newborns
      • 5.1.1.2. Surge in point-of-care testing driving convenience and faster results for bilirubin levels
      • 5.1.1.3. Higher incidence of hemolytic diseases requiring frequent bilirubin monitoring contributing to market growth
      • 5.1.1.4. Government health policies and funding favoring advancements and accessibility of bilirubin testing
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of skilled healthcare professionals trained in bilirubin testing techniques, especially in rural areas
      • 5.1.2.2. Long approval process for new bilirubin test methods and technologies by regulatory bodies
    • 5.1.3. Opportunities
      • 5.1.3.1. Healthcare policies supporting widespread adoption of bilirubin blood tests in rural areas
      • 5.1.3.2. Rising awareness about neonatal jaundice leading to increased bilirubin testing demand
      • 5.1.3.3. Partnerships between hospitals and research institutions for innovative bilirubin test solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Supply chain disruptions affecting timely and cost-efficient distribution of bilirubin blood test kits
      • 5.1.4.2. Regulatory challenges in approval processes leading to delayed introduction of innovative bilirubin testing technologies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bilirubin Blood Test Market, by Test Type

  • 6.1. Introduction
  • 6.2. Delta Bilirubin Test
  • 6.3. Direct Bilirubin (DBIL) Test
  • 6.4. Indirect Bilirubin (IBIL) Test
  • 6.5. Total Serum Bilirubin (TSB) Test
    • 6.5.1. Direct (Conjugated) Bilirubin Test
    • 6.5.2. Indirect (Unconjugated) Bilirubin Test

7. Bilirubin Blood Test Market, by End User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers (ASCs)
  • 7.3. Diagnostic Laboratories
  • 7.4. Home Care Settings
  • 7.5. Hospitals
  • 7.6. Research Institutes

8. Bilirubin Blood Test Market, by Application

  • 8.1. Introduction
  • 8.2. Bile Duct Obstruction
  • 8.3. Drug-Related Toxicity
  • 8.4. Hemolytic Anemia
  • 8.5. Liver Diseases
  • 8.6. Newborn Jaundice

9. Bilirubin Blood Test Market, by Product

  • 9.1. Introduction
  • 9.2. Instruments
  • 9.3. Reagents & Kits

10. Americas Bilirubin Blood Test Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Bilirubin Blood Test Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Bilirubin Blood Test Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies
  • 3. Beckman Coulter
  • 4. Bio-Rad Laboratories
  • 5. DiaSorin
  • 6. Fujifilm Holdings Corporation
  • 7. GE Healthcare
  • 8. Horiba Medical
  • 9. Mindray
  • 10. PerkinElmer
  • 11. Philips Healthcare
  • 12. Quidel Corporation
  • 13. Randox Laboratories
  • 14. Roche Diagnostics
  • 15. Siemens Healthineers
  • 16. Sysmex Corporation
  • 17. Thermo Fisher Scientific
  • 18. Tosoh Bioscience
  • 19. Trinity Biotech

LIST OF FIGURES

  • FIGURE 1. BILIRUBIN BLOOD TEST MARKET RESEARCH PROCESS
  • FIGURE 2. BILIRUBIN BLOOD TEST MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BILIRUBIN BLOOD TEST MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BILIRUBIN BLOOD TEST MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BILIRUBIN BLOOD TEST MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BILIRUBIN BLOOD TEST MARKET DYNAMICS
  • TABLE 7. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DELTA BILIRUBIN TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DIRECT BILIRUBIN (DBIL) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY INDIRECT BILIRUBIN (IBIL) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DIRECT (CONJUGATED) BILIRUBIN TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY INDIRECT (UNCONJUGATED) BILIRUBIN TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY BILE DUCT OBSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DRUG-RELATED TOXICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY HEMOLYTIC ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY LIVER DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY NEWBORN JAUNDICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. BILIRUBIN BLOOD TEST MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 240. BILIRUBIN BLOOD TEST MARKET, FPNV POSITIONING MATRIX, 2023